Cannabinoid treatment for children with hard-to-treat cancers
Part of Cancer, Mental health clinical trials.
This early-phase study tests whether a cannabinoid medicine (including nabilone/cannabis-based treatment) can be given safely to children and teens with relapsed or refractory cancer. It may help with treatment options for children whose cancer has come back or did not respond to standard therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 4 and 17 years old at enrollment.
- Have a solid tumor or blood cancer that has come back (relapsed) or is not responding (refractory), including brain tumors.
- Be getting active cancer treatment or supportive/palliative care right now.
- Have an expected survival of at least 4 months.
- Be able to stop cannabis/nabilone use for the past 2 weeks and not use it during the study (or be willing to follow this rule).
- Not have major heart problems, very poor liver/kidney function, unstable heart rhythm, uncontrolled high blood pressure, or recent heart attack.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a daily oral cannabis (marijuana) dose is safe for people with advanced solid tumors (cancer that has spread). It's looking for people who are already on a stable cancer treatment and want to see if adding cannabis affects their symptoms or how they feel.
This trial tests personalized cancer treatments for children and teens whose cancer has not responded to standard therapy. It uses information from precision medicine studies to match the right drug to each child's tumor.
This study looks at how medical cannabis is used for children and teens in everyday life, by collecting information through online questionnaires. It may help doctors and families better understand which uses are common and how people experience them.
This study looks at how cannabis affects symptoms in cancer patients who are getting immunotherapy. It may help understand if cannabis can improve pain and quality of life during treatment.
This trial studies whether cannabis can reduce chronic migraine headaches in adolescents who have not improved with other treatments. It also asks participants to work with psychology and physiotherapy during the study.
This early-phase study tests medicinal cannabis to help improve symptoms like pain, muscle stiffness (dystonia), and gut problems in children who are receiving palliative care for non-cancer conditions. You may be asked to follow a medication schedule and not start or change other treatments right before joining.
Hear when a new Childhood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.